Uma Sinha, Chief Scientific Officer at BridgeBio Pharma, Inc. (BBIO), bought 14,000 shares at $17.00 ($238K) on 2019-07-01, disclosed to the SEC on 2019-07-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| EIDX | SELL | 2020-10-30 | $456K | — | Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |